Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
September 11 2020 - 8:00AM
Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical
company committed to developing medicines that transform the lives
of people with rare neurological diseases, today announced that
management will present at the 2020 Cantor Fitzgerald Virtual
Global Healthcare Conference on Thursday, September 17, 2020, at
2:00 p.m. ET.
A live audio webcast of the discussion can be
accessed through the Events & Presentations section of the
Company's website at investors.ovidrx.com. An archived replay
of the webcast will be available on the Company's website following
the live presentation.
About Ovid Therapeutics Ovid
Therapeutics Inc. is a New York-based biopharmaceutical company
using its BoldMedicine® approach to develop medicines that
transform the lives of patients with rare neurological disorders.
Ovid has a broad pipeline of potential first-in-class medicines.
The Company’s most advanced investigational medicine, OV101
(gaboxadol), is currently in clinical development for the treatment
of Angelman syndrome and Fragile X syndrome. Ovid is also
developing OV935 (soticlestat) in collaboration with Takeda
Pharmaceutical Company Limited for the potential treatment of rare
developmental and epileptic encephalopathies (DEE). For more
information on Ovid, please visit www.ovidrx.com.
Contacts
Investors and Media: Ovid
Therapeutics Inc. Investor Relations & Public Relations
irpr@ovidrx.com
Or
Investors: Steve Klass Burns
McClellan, Inc. sklass@burnsmc.com (212) 213-0006
Media: Katie Engleman 1AB
katie@1abmedia.com
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Sep 2023 to Sep 2024